VRDN-003-302: A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with chronic thyroid eye disease (TED) REVEAL 2
- Title
- A phase 3, randomized, double-masked, placebo-controlled, efficacy, safety, and tolerability study of VRDN-003 in participants with chronic thyroid eye disease (TED) REVEAL 2
- Principal Investigator
- Nguyen, John
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Other
- Participating Institutions
- Eye Institute
- West Virginia University
- Contacts
- Emalee Taylor
- Certified Ophthalmic Assistant
- Email: emalee.taylor@wvumedicine.org